Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.1M |
| 2 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$34.8M |
| 3 |
WOOF
VCA Inc.
WOOF
|
+$33.2M |
| 4 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$30.7M |
| 5 |
DaVita
DVA
|
+$30.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$170M |
| 2 |
STJ
St Jude Medical
STJ
|
+$40.7M |
| 3 |
Danaher
DHR
|
+$37.7M |
| 4 |
Mettler-Toledo International
MTD
|
+$34M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$32.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.81% |
| 2 | Consumer Discretionary | 10.65% |
| 3 | Industrials | 10.41% |
| 4 | Healthcare | 10.37% |
| 5 | Technology | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AJRD
676
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $506K | 0.02% |
+23,327
| New | +$461K |
|
|
VISN
677
Vistance Networks Inc
VISN
$2.59B
| $505K | 0.02% |
12,114
-75,575
| -86% | -$2.91M |
|
678
Deluxe
DLX
$1.08B
| $505K | 0.02% |
6,995
-4,213
| -38% | -$309K |
|
679
La-Z-Boy
LZB
$1.35B
| $505K | 0.02% |
18,706
+8,777
| +88% | +$249K |
|
680
Capital One
COF
$134B
| $503K | 0.02% |
5,800
-2,871
| -33% | -$256K |
|
|
GTLS
681
DELISTED
Chart Industries
GTLS
| $503K | 0.02% |
14,402
+5,311
| +58% | +$197K |
|
682
Planet Fitness
PLNT
$4.09B
| $503K | 0.02% |
26,100
+8,781
| +51% | +$181K |
|
|
AMAG
683
DELISTED
AMAG Pharmaceuticals
AMAG
| $503K | 0.02% |
22,300
+11,100
| +99% | +$266K |
|
684
Regis Corp
RGS
$66.9M
| $502K | 0.02% |
2,143
+658
| +44% | +$171K |
|
685
The RMR Group
RMR
$342M
| $501K | 0.02% |
10,125
-819
| -7% | -$38.9K |
|
686
United Therapeutics
UTHR
$22B
| $501K | 0.02% |
3,700
+166
| +5% | +$25.1K |
|
687
Public Storage
PSA
$60.2B
| $500K | 0.02% |
+2,284
| New | +$506K |
|
688
YPF Sociedad Anonima ADS
YPF
$20.1B
| $500K | 0.02% |
+20,605
| New | +$444K |
|
|
DFS
689
DELISTED
Discover Financial Services
DFS
| $499K | 0.02% |
7,294
+3,694
| +103% | +$259K |
|
690
HCA Healthcare
HCA
$92.9B
| $499K | 0.02% |
5,607
-1,393
| -20% | -$116K |
|
691
Hilltop Holdings
HTH
$2.22B
| $496K | 0.02% |
18,052
+6,221
| +53% | +$174K |
|
|
CTLT
692
DELISTED
CATALENT, INC.
CTLT
| $496K | 0.02% |
17,521
+4,021
| +30% | +$112K |
|
693
Lumen
LUMN
$6.13B
| $495K | 0.02% |
21,000
-800
| -4% | -$19.5K |
|
|
ACC
694
DELISTED
American Campus Communities, Inc.
ACC
| $495K | 0.02% |
+10,401
| New | +$508K |
|
|
USCR
695
DELISTED
U S Concrete, Inc.
USCR
| $494K | 0.02% |
+7,651
| New | +$495K |
|
|
BBT
696
Beacon Financial Corp
BBT
$2.65B
| $492K | 0.02% |
13,650
-11,259
| -45% | -$398K |
|
697
BOK Financial
BOKF
$8.54B
| $492K | 0.02% |
6,284
-118
| -2% | -$9.62K |
|
698
AngioDynamics
ANGO
$651M
| $491K | 0.02% |
28,301
+3,327
| +13% | +$55.6K |
|
699
Coherus Oncology
CHRS
$219M
| $491K | 0.02% |
23,223
+8,827
| +61% | +$217K |
|
700
Avnet
AVT
$7.27B
| $490K | 0.02% |
10,700
+4,800
| +81% | +$222K |
|
Similar funds
Paul Tudor Jones's Q1 2017 Portfolio in Review
As of Q1 2017, Paul Tudor Jones held 1,687 positions worth $3.25B, down 16% from $3.88B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Paul Tudor Jones withdrew a net $793M in Q1 2017, closing 340 positions and reducing 514 holdings. Its most notable exit was St Jude Medical, an estimated $40.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Paul Tudor Jones opened a new position in iShares MSCI Emerging Markets ETF worth $72.8M.
- Paul Tudor Jones's largest Q1 2017 buy was iShares MSCI Emerging Markets ETF: 1,847,000 shares worth $72.8M.
- Paul Tudor Jones added most to Mead Johnson Nutrition Company in Q1 2017, an estimated $30.7M increase.
- Paul Tudor Jones's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $170M.
- Paul Tudor Jones fully exited St Jude Medical in Q1 2017, selling an estimated $40.7M.
- Paul Tudor Jones's ten largest holdings make up 31% of its $3.25B portfolio in Q1 2017.
- Paul Tudor Jones opened 332 new positions and closed 340 in Q1 2017.
- Paul Tudor Jones's portfolio value fell 16% quarter-over-quarter to $3.25B.
Based on Tudor Investment Corp's 13F filing for Q1 2017, filed 15 May 2017.